menu Search
Zuellig

AMGEN MANUFACTURING LIMITED

Featured products of Amgen
Kanjinti
Kanjinti powd for conc for soln for infusion 150 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Mvasi
Mvasi infusion conc 100 mg/4 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Mvasi infusion conc 400 mg/16 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Neulastim
Neulastim soln for inj 6 mg/0.6 mL
pegfilgrastim
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen soln for inj 300 mcg/mL
filgrastim
Packing/Price
4 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1 mL x 1's (P18,490.00/prefilled syringe)
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
1 mL x 1's ((auto-injector)) 1 mL x 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix infusion conc 20 mg/mL
panitumumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
Xgeva
Xgeva 120 mg/1.7 mL (70 mg/mL)
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Distributed by Zuellig
Kanjinti
Kanjinti powd for conc for soln for infusion 150 mg
trastuzumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Mvasi
Mvasi infusion conc 100 mg/4 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Mvasi infusion conc 400 mg/16 mL
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor / Receptors) inhibitors. Used in the treatment of cancer.
Neulastim
Neulastim soln for inj 6 mg/0.6 mL
pegfilgrastim
Packing/Price
(pre-filled syringe) 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Neupogen
Neupogen soln for inj 300 mcg/mL
filgrastim
Packing/Price
4 × 1's
MIMS Class
Haematopoietic Agents, Supportive Care Therapy
ATC Classification
L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.
Prolia
Prolia soln for inj 60 mg/mL
denosumab
Packing/Price
1 mL x 1's (P18,490.00/prefilled syringe)
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.
Repatha
Repatha soln for inj 140 mg/mL
evolocumab
Packing/Price
1 mL x 1's ((auto-injector)) 1 mL x 1's
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.
Vectibix
Vectibix infusion conc 20 mg/mL
panitumumab
Packing/Price
5 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.
Xgeva
Xgeva 120 mg/1.7 mL (70 mg/mL)
denosumab
Packing/Price
1's
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.